Editorials |
From the Department of Internal Medicine, University of Iowa and the VA Medical Center, Iowa City.
Correspondence to Kathryn Lamping, PhD, Medical Services (111), VA Medical Center, Iowa City, IA 52246. E-mail kathryn-lamping@uiowa.edu
Key Words: nitric oxide cAMP cGMP coronary circulation nitric oxide synthase
Amajor focus of studies in vascular biology has been the role of the endothelium in modulating tone of vascular smooth muscle by release of nitric oxide (NO), stimulation of soluble guanylate cyclase, and the subsequent increase in intracellular cyclic guanosine monophosphate (cGMP). An alternative second-messenger pathway that plays a key role in eliciting relaxation of vascular muscle involves receptor-mediated activation of adenylate cyclase, formation of cAMP, and activation of protein kinase A and myosin light-chain kinase within smooth muscle cells. In general, cAMP-mediated relaxation of vascular smooth muscle does not involve the endothelium. Although most studies suggest that vasorelaxation to many agents is mediated by release of cGMP or cAMP alone, several studies have suggested that some "typical endothelium-independent" vasodilators may also release NO and activate guanylate cyclase.1 2 3 4 5 6 7 8 9 10 11 12 13 Relaxation to some classic endothelium-independent agents, including adenosine, prostacyclin, forskolin, and ß-receptor agonists, is reduced by inhibitors of NO synthase (NOS).1 2 3 4 5 6 7 8 9 10 11 12 13 These studies suggest that relaxation of vascular smooth muscle to selected endothelium-independent agents is mediated by an interaction between cGMP and cAMP pathways.
Complex interactions between different vasodilator
pathways in vascular smooth muscle have been proposed for
cyclooxygenase and NOS. For example, inhibition of
either cyclooxygenase or NOS abolished the increase
in cerebral blood flow in response to
hypercapnia.14 15
Acute or chronic inhibition of NOS enhanced the role of
cyclooxygenase in the regulation of vascular
resistance in the coronary and renal
circulations.16 17 18
In the coronary circulation of humans with
atherosclerosis, inhibitors of both NOS or
cyclooxygenase reduced flow-mediated
response.19 These studies
This article has been cited by other articles:
![]() |
T. Matsumoto, K. Wakabayashi, T. Kobayashi, and K. Kamata Functional changes in adenylyl cyclases and associated decreases in relaxation responses in mesenteric arteries from diabetic rats Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2234 - H2243. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matsumoto, K. Wakabayashi, T. Kobayashi, and K. Kamata Diabetes-related changes in cAMP-dependent protein kinase activity and decrease in relaxation response in rat mesenteric artery Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1064 - H1071. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Schiffrin and R. M. Touyz From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H435 - H446. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |